Literature DB >> 11751580

The [URE3] phenotype: evidence for a soluble prion in yeast.

Eric Fernandez-Bellot1, Elisabeth Guillemet, Frederique Ness, Agnes Baudin-Baillieu, Leslie Ripaud, Mick Tuite, Christophe Cullin.   

Abstract

The aggregation of the two yeast proteins Sup35p and Ure2p is widely accepted as a model for explaining the prion propagation of the phenotypes [PSI+] and [URE3], respectively. Here, we demonstrate that the propagation of [URE3] cannot simply be the consequence of generating large aggregates of Ure2p, because such aggregation can be found in some conditions that are not related to the prion state of Ure2p. A comparison of [PSI+] and [URE3] aggregation demonstrates differences between these two prion mechanisms. Our findings lead us to propose a new unifying model for yeast prion propagation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11751580      PMCID: PMC1083930          DOI: 10.1093/embo-reports/kvf011

Source DB:  PubMed          Journal:  EMBO Rep        ISSN: 1469-221X            Impact factor:   8.807


  21 in total

1.  Structural characterization of Saccharomyces cerevisiae prion-like protein Ure2.

Authors:  C Thual; A A Komar; L Bousset; E Fernandez-Bellot; C Cullin; R Melki
Journal:  J Biol Chem       Date:  1999-05-07       Impact factor: 5.157

2.  Prion domain initiation of amyloid formation in vitro from native Ure2p.

Authors:  K L Taylor; N Cheng; R W Williams; A C Steven; R B Wickner
Journal:  Science       Date:  1999-02-26       Impact factor: 47.728

3.  In vitro propagation of the prion-like state of yeast Sup35 protein.

Authors:  S V Paushkin; V V Kushnirov; V N Smirnov; M D Ter-Avanesyan
Journal:  Science       Date:  1997-07-18       Impact factor: 47.728

4.  Self-seeded fibers formed by Sup35, the protein determinant of [PSI+], a heritable prion-like factor of S. cerevisiae.

Authors:  J R Glover; A S Kowal; E C Schirmer; M M Patino; J J Liu; S Lindquist
Journal:  Cell       Date:  1997-05-30       Impact factor: 41.582

5.  Equilibrium folding properties of the yeast prion protein determinant Ure2.

Authors:  S Perrett; S J Freeman; P J Butler; A R Fersht
Journal:  J Mol Biol       Date:  1999-07-02       Impact factor: 5.469

6.  Characterization of the interaction domains of Ure2p, a prion-like protein of yeast.

Authors:  E Fernandez-Bellot; E Guillemet; A Baudin-Baillieu; S Gaumer; A A Komar; C Cullin
Journal:  Biochem J       Date:  1999-03-01       Impact factor: 3.857

7.  The [URE3] prion is an aggregated form of Ure2p that can be cured by overexpression of Ure2p fragments.

Authors:  H K Edskes; V T Gray; R B Wickner
Journal:  Proc Natl Acad Sci U S A       Date:  1999-02-16       Impact factor: 11.205

8.  Enhanced expression of the yeast Ure2 protein in Escherichia coli: the effect of synonymous codon substitutions at a selected place in the gene.

Authors:  A A Komar; E Guillemet; C Reiss; C Cullin
Journal:  Biol Chem       Date:  1998-10       Impact factor: 3.915

9.  The dominant PNM2- mutation which eliminates the psi factor of Saccharomyces cerevisiae is the result of a missense mutation in the SUP35 gene.

Authors:  S M Doel; S J McCready; C R Nierras; B S Cox
Journal:  Genetics       Date:  1994-07       Impact factor: 4.562

10.  Mechanism of inhibition of Psi+ prion determinant propagation by a mutation of the N-terminus of the yeast Sup35 protein.

Authors:  N V Kochneva-Pervukhova; S V Paushkin; V V Kushnirov; B S Cox; M F Tuite; M D Ter-Avanesyan
Journal:  EMBO J       Date:  1998-10-01       Impact factor: 11.598

View more
  13 in total

1.  Amyloid aggregates of the HET-s prion protein are infectious.

Authors:  Marie-Lise Maddelein; Suzana Dos Reis; Stéphane Duvezin-Caubet; Bénédicte Coulary-Salin; Sven J Saupe
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-28       Impact factor: 11.205

2.  Changes in the middle region of Sup35 profoundly alter the nature of epigenetic inheritance for the yeast prion [PSI+].

Authors:  Jia-Jia Liu; Neal Sondheimer; Susan L Lindquist
Journal:  Proc Natl Acad Sci U S A       Date:  2002-12-02       Impact factor: 11.205

Review 3.  Prions in yeast.

Authors:  Susan W Liebman; Yury O Chernoff
Journal:  Genetics       Date:  2012-08       Impact factor: 4.562

4.  Real-time imaging of yeast cells reveals several distinct mechanisms of curing of the [URE3] prion.

Authors:  Xiaohong Zhao; Jenna Lanz; Danielle Steinberg; Tyler Pease; Joseph M Ahearn; Evgeny E Bezsonov; Elena D Staguhn; Evan Eisenberg; Daniel C Masison; Lois E Greene
Journal:  J Biol Chem       Date:  2018-01-12       Impact factor: 5.157

5.  Antagonistic interactions between yeast [PSI(+)] and [URE3] prions and curing of [URE3] by Hsp70 protein chaperone Ssa1p but not by Ssa2p.

Authors:  Christine Schwimmer; Daniel C Masison
Journal:  Mol Cell Biol       Date:  2002-06       Impact factor: 4.272

6.  The mechanisms of [URE3] prion elimination demonstrate that large aggregates of Ure2p are dead-end products.

Authors:  Leslie Ripaud; Laurent Maillet; Christophe Cullin
Journal:  EMBO J       Date:  2003-10-01       Impact factor: 11.598

7.  Effects of Q/N-rich, polyQ, and non-polyQ amyloids on the de novo formation of the [PSI+] prion in yeast and aggregation of Sup35 in vitro.

Authors:  Irina L Derkatch; Susan M Uptain; Tiago F Outeiro; Rajaraman Krishnan; Susan L Lindquist; Susan W Liebman
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-23       Impact factor: 11.205

Review 8.  Application of GFP-labeling to study prions in yeast.

Authors:  Lois E Greene; Yang-Nim Park; Daniel C Masison; Evan Eisenberg
Journal:  Protein Pept Lett       Date:  2009       Impact factor: 1.890

Review 9.  Prion dynamics and the quest for the genetic determinant in protein-only inheritance.

Authors:  Suzanne S Sindi; Tricia R Serio
Journal:  Curr Opin Microbiol       Date:  2009-10-26       Impact factor: 7.934

10.  The cellular concentration of the yeast Ure2p prion protein affects its propagation as a prion.

Authors:  Myriam Crapeau; Christelle Marchal; Christophe Cullin; Laurent Maillet
Journal:  Mol Biol Cell       Date:  2009-02-18       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.